Best Real Estate Podcasts 2026

BiggerPockets Real Estate Podcast

BiggerPockets

3x/week

Dave Meyer and the BiggerPockets team share real strategies from real estate investors building wealth right now. The largest RE investing community's flagship show.

→ WHAT IT COVERS Grace Guttenkopf and Amelia Magee, Iowa-based investors with 25–40 doors each, share five lessons from five years of real estate inve

All-In with Chamath, Jason, Sacks & Friedberg

All-In Podcast, LLC

2x/week

Four tech billionaires debate markets, politics, and science with zero filter. The most influential group chat in Silicon Valley, now public.

→ WHAT IT COVERS SpaceX completes history's largest IPO at $85B raised, valuing the company above $2T and making Elon Musk the world's first trilliona

Odd Lots

Daily

Bloomberg's Joe Weisenthal and Tracy Alloway explore the weird, wonderful corners of markets and economics that mainstream finance media ignores.

→ WHAT IT COVERS Independent AI researcher Grace Shao joins Odd Lots in Hong Kong to explain how Chinese AI labs like DeepSeek, MiniMax, Moonshot, and

Citeline Podcasts

Daily

Industry intelligence on clinical trials, regulatory trends, and pharma strategy from Citeline's expert analysts.

→ WHAT IT COVERS Generics Bulletin editors report from two February 2026 industry conferences — AAM's Access meeting in Miami and Medicines for Europe

Invest Like the Best with Patrick O'Shaughnessy

Colossus | Investing & Business Podcasts

Weekly

Patrick O'Shaughnessy interviews the world's best investors and operators. Deep, patient conversations you won't find anywhere else in finance media.

→ WHAT IT COVERS Kareem Amin, cofounder and CEO of Clay — a go-to-market software company valued at over $4 billion — shares the unconventional princi

20VC (20 Minute VC)

3x/week

Harry Stebbings interviews the biggest names in venture capital — 20 minutes, no filler. The most connected VC pod in the ecosystem.

→ WHAT IT COVERS Palo Alto Networks CEO Nikesh Arora analyzes where AI value accrues across infrastructure, models, and applications, explaining why e

Investing for Beginners

3x/week

Andrew Sather and Dave Ahern teach investing from scratch — stock analysis, value investing, and portfolio building for complete beginners.

→ WHAT IT COVERS Stephen Morris and Andrew Sather break down why a stock's P/E ratio turns negative, identifying three root causes — real operating lo

Stacking Benjamins

3x/week

Joe Saul-Sehy and his team make personal finance entertaining and approachable. Practical money advice served with genuine humor.

→ WHAT IT COVERS Amy Minkley, host of the Financial Independence Freedom Retreat in Bali, joins Stacking Benjamins to discuss how the FIRE movement ha

In Good Company with Nicolai Tangen

2x/week

The CEO of Norway's $1.7 trillion sovereign wealth fund interviews the world's top business leaders. Unmatched access, understated brilliance.

→ WHAT IT COVERS Snowflake CEO Sridhar Ramaswamy speaks with Nicolai Tangen about how AI agents are fundamentally restructuring software engineering,

Bankless

3x/week

Ryan Sean Adams and David Hoffman explore crypto, Ethereum, and DeFi with depth and conviction. The intellectual home of the Ethereum community.

→ WHAT IT COVERS Geopolitical analyst Kamran Bokhari explains the strategic logic behind the U.S.-Iran war as part of a broader American grand strateg

This Week in Startups

3x/week

Jason Calacanis covers startup news, interviews founders, and shares unfiltered opinions on tech and investing. The OG startup podcast.

→ WHAT IT COVERS Two separate segments: Louis Phillips demos Interval, a territory-claiming gamified running app with 1 million downloads built by a t

We Study Billionaires

2x/week

Warren Buffett-style investing education. Stig and Preston break down the strategies of legendary investors with clarity and intellectual honesty.

→ WHAT IT COVERS Stig Brodersen, Tobias Carlisle, and Hari Ramachandra pitch three AI-pressured stocks — Meta, Booking Holdings, and Adobe — each trad

So Money with Farnoosh Torabi

3x/week

Farnoosh Torabi covers money, career, and life with a blend of expert interviews and listener Q&A. Approachable, smart personal finance.

→ WHAT IT COVERS Nikki Mamano, author of memoir Breaking Good , recounts her path from teenage trauma and addiction to running a drug operation in Ha

The Money Guy Show

3x/week

Brian Preston and Bo Hanson help everyday Americans build wealth with practical financial planning. Approachable, systematic, and trustworthy.

→ WHAT IT COVERS Brian Preston and Bo Hansen evaluate car brands using a "cruise or snooze" framework, revealing which vehicles destroy wealth versus

Beyond Biotech

Weekly

Labiotech.eu's official podcast — broad global coverage of biotech news, partnerships, and emerging therapies. Great for a European perspective on drug development.

→ WHAT IT COVERS Werner Lanthaler, former Evotec CEO who scaled the company from 200 employees and €40M to 5,000 staff and €800M revenue, shares pract

The Compound and Friends

2x/week

Investing podcast with Downtown Josh Brown, Michael Batnick, and rotating guests for expert insight and hot takes on business and investing.

BiggerPockets Money Podcast

BiggerPockets

2x/week

Mindy Jensen and Scott Trench go beyond budgeting basics into real estate investing, side income, and FIRE strategies for the financially ambitious.

→ WHAT IT COVERS Mindy Jensen and Scott Trench identify 13 financial independence mistakes split into 5 obvious errors and 8 subtle ones, covering com

What Bitcoin Did

2x/week

Peter McCormack interviews Bitcoin builders, economists, and skeptics. Balanced, curious, and the most respected Bitcoin-focused podcast.

→ WHAT IT COVERS Peter McCormack and academic Neema Parvini examine why populist movements like Trump's MAGA and UK Reform consistently fail to delive

Animal Spirits

2x/week

Ben Carlson and Michael Batnick discuss markets, investing, and the economy with humor and humility. No pretense, just smart takes.

→ WHAT IT COVERS Ben Carlson and Michael Batnick analyze oil markets amid Middle East conflict, debating whether current conditions mirror February 20

Masters in Business

2x/week

Bloomberg's Barry Ritholtz interviews the biggest names in finance and investing. Long-running, consistently excellent, and refreshingly direct.

→ WHAT IT COVERS Francine Lacqua, award-winning journalist with 25 years interviewing global leaders, launches the podcast version of Leaders, explori

The Full Ratchet

Weekly

Nick Moran covers VC deal mechanics, startup metrics, and fund management with rare transparency. A masterclass in venture investing.

→ WHAT IT COVERS David Ulevitch, General Partner at Andreessen Horowitz leading the $1.8B American Dynamism fund, covers investing in defense, energy,

Afford Anything

2x/week

Paula Pant teaches that you can afford anything but not everything. Practical personal finance with an emphasis on intentional spending.

→ WHAT IT COVERS Paula Pant and Joe Saul-Sehy answer three listener questions: whether a dual-income federal employee couple earning $325K should paus

Capital Allocators

Weekly

Ted Seides interviews the world's top institutional investors — endowments, pensions, and sovereign wealth funds. The allocator's allocator podcast.

→ WHAT IT COVERS Will Guidara, co-owner of Eleven Madison Park when it ranked number one in the world, explains how businesses can systematize excepti

Business Of Biotech

Weekly

Ben Comer (Life Science Leader) interviews biotech CEOs on the operational realities of building a drug company — from fundraising to commercialization.

→ WHAT IT COVERS Marc Hedrick, CEO of Plus Therapeutics, details the development of Rhenium-186 radiotherapeutic Rayovik for CNS cancers including gli

The Long Run with Luke Timmerman

Biweekly

Veteran biotech journalist Luke Timmerman goes deep with CEOs, VCs, and scientists. Thoughtful long-form interviews that reveal the people and strategies behind biotech companies.

→ WHAT IT COVERS Sri Kosuri, cofounder and CEO of Octant Bio, describes how the company builds oral small molecule correctors targeting protein misfol

The James Altucher Show

Weekly

James Altucher's wide-ranging interviews span investing, entrepreneurship, and personal reinvention. Unpredictable and always thought-provoking.

→ WHAT IT COVERS Six-time USA Memory Champion Nelson Dellis joins James Altucher to discuss his book Everyday Genius , covering memory palace techniq

Biotech Hangout

Weekly

Friday roundtable with Daphne Zohar, Brad Loncar, and rotating guests. Fast-paced weekly recap of biotech news, deals, and FDA actions — like a biotech happy hour with insiders.

→ WHAT IT COVERS Biotech Hangout Episode 186 covers mid-2026 biotech market performance, with XBI up 10.5% year-to-date, a record $771M Parabolas IPO,

The Meb Faber Show

Weekly

Meb Faber covers quantitative investing, asset allocation, and global markets with data-driven clarity. The quant investor's podcast.

→ WHAT IT COVERS Wes Gray and tax analyst Brent Sullivan join Meb Faber to examine IRC Section 351 ETF seeding strategies, the IRS scrutiny targeting

Macro Voices

Weekly

Weekly market commentary by hedge fund manager Erik Townsend with interviews from the brightest minds in finance and macroeconomics.

Rational Reminder

Weekly

Ben Felix and Cameron Passmore bring academic finance research to retail investors. Evidence-based investing with intellectual rigor.

→ WHAT IT COVERS Recorded at the New York Stock Exchange for a Vanguard/S&P event marking 50 years of retail index investing, Ben Felix moderates a pa

The RTW Podcast

Monthly

Real-time commentary on biotech investing trends, clinical data readouts, and sector dynamics from an investment research perspective.

→ WHAT IT COVERS Rod Wong, founder and CIO of RTW Investments, traces biotech's evolution from the 2000 Human Genome Project through today's commercia

Hidden Forces

Weekly

Demetri Kofinas explores the unseen forces driving change in markets, technology, and geopolitics. Deep, contrarian, and intellectually fearless.

→ WHAT IT COVERS Iranian scholar Hamidreza Azizi analyzes the US-Israeli military campaign against Iran through week three, examining divergent Americ

BioCentury This Week

Weekly

The gold standard for weekly biotech industry analysis. BioCentury's editorial team breaks down deals, clinical data, and regulatory moves with investor-grade rigor.

→ WHAT IT COVERS BioCentury This Week examines biotech capital markets momentum amid geopolitical uncertainty, Xenon Pharmaceuticals' phase three epil

The Bio Report

Weekly

Award-winning biotech journalist Daniel Levine covers where biotechnology meets business, policy, and science. Concise, well-researched episodes for busy professionals.

→ WHAT IT COVERS Immuneering CEO Ben Zeskind explains how the company's informatics-driven "deep cyclic inhibition" approach to MEK inhibition deliver

Her First $100K

Weekly

Tori Dunlap makes financial empowerment accessible and unapologetic. Personal finance and investing advice built for women building wealth.

→ WHAT IT COVERS Erin Gallagher, CEO of Hype Woman and author of the book Hype Woman , walks through her framework for breaking patriarchal self-aban

The Money Mondays

Monthly

Dan Fleyshman hosts fast-paced conversations about making money, investing, and building businesses. Entrepreneurial energy in every episode.

→ WHAT IT COVERS Garrett White, founder of Wake Up Warrior with 90,000 clients trained, breaks down the three-stage psychological barrier men face aro

Alt Goes Mainstream

Weekly

Robert Picard explores how alternative investments and private markets are going mainstream. WealthTech, secondaries, and the democratization of alts.

→ WHAT IT COVERS EQT Deputy Managing Partner Lennart Blecher traces the evolution of infrastructure investing from core asset ownership to active oper

Venture Stories

Biweekly

Village Global's interviews with founders, VCs, and startup operators. Pattern recognition from across the venture ecosystem.

→ WHAT IT COVERS Sumeet Singh of Worldbuild presents the Model Economy framework, arguing that AI scaling laws will eliminate most specialist SaaS-sty

Pathfinders in Biopharma

Biweekly

Biopharma leaders share how they navigated the path from discovery to commercialization. Hard-won lessons from drug development veterans.

→ WHAT IT COVERS RBC Capital Markets analyst Brian Abrams assesses biotech's 80% rally from April 2025 lows, evaluating whether sector momentum can pe

BG2Pod with Brad Gerstner and Bill Gurley

Brad Gerstner & Bill Gurley

Monthly

Brad Gerstner and Bill Gurley — two of tech's sharpest investors — debate markets, startups, and capitalism. Rare public conversations between elite VCs.

→ WHAT IT COVERS Nick Turley, Head of Product at ChatGPT, covers how OpenAI scaled from a demo to 900 million weekly active users, the one-third frame

Biotech 2050 Podcast

Monthly

Forward-looking conversations on where biotech is headed — gene therapy, synthetic biology, and the next-gen platform technologies reshaping drug discovery.

→ WHAT IT COVERS Adial Pharmaceuticals CEO Cary Claiborne explains how AD04, a repurposed low-dose ondansetron, targets a specific genetic biomarker f

Business Breakdowns

Biweekly

Colossus analysts reverse-engineer what makes great businesses tick. Like getting an MBA case study every week, but from practitioners, not professors.

→ WHAT IT COVERS Sean Barrett, CIO at Counter Global, breaks down Toast — the cloud-based point-of-sale and restaurant operating system holding 20% US

Biotech Bulls & Breakthroughs

Monthly

Focused on small-cap and mid-cap biotech catalysts — phase 3 data readouts, FDA decisions, and the binary events that move stocks. Essential for biotech investors.

→ WHAT IT COVERS Biotech trader Jeff "Chef" reviews how the FDA's one-pivotal-trial rule produced a landmark win for Outlook Therapeutics (OTLK), then

The Pitch

Monthly

Real founders pitch real investors, and you hear every question, objection, and negotiation. The most authentic view into early-stage fundraising.

→ WHAT IT COVERS Three pre-seed founders pitch three VCs live in New York City with only 15 minutes each — half the usual 45-minute format. Uche AI (c

Grant's Current Yield Podcast

James Grant's institutional-grade analysis of interest rates, credit markets, and fixed income. Essential for serious bond investors.

→ WHAT IT COVERS Dan Zwirn of Arena Investors explains how monetary and fiscal policy since 2013 created massive asset bubbles now slowly deflating th

All the Credit

PGIM Fixed Income analysts break down global credit markets, rates, and macro trends. Institutional-grade fixed income intelligence.

→ WHAT IT COVERS PGIM's Greg Peters and Tom McCartan explain how to construct portfolios combining public and private credit assets. They address chal